Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.
Burm R, Maravelia P, Ahlen G, Ciesek S, Caro Perez N, Pasetto A, Urban S, Van Houtte F, Verhoye L, Wedemeyer H, Johansson M, Frelin L, Sällberg M, Meuleman P.
Burm R, et al. Among authors: caro perez n.
Gut. 2023 Jun;72(6):1186-1195. doi: 10.1136/gutjnl-2022-327216. Epub 2022 Aug 17.
Gut. 2023.
PMID: 35977815
Free PMC article.